Literature DB >> 12036910

Inactivation and degradation of O(6)-alkylguanine-DNA alkyltransferase after reaction with nitric oxide.

Liping Liu1, Meng Xu-Welliver, Sreenivas Kanugula, Anthony E Pegg.   

Abstract

O(6)-Alkylguanine-DNA alkyltransferase (AGT) plays a critical role in protection from the carcinogenic effects of simple alkylating agents by repairing O(6)-alkylguanine adducts via a direct transfer reaction. Nitric oxide (NO) or species derived from it are known to be able to initiate neoplastic growth and cannot only damage DNA, either directly or via the formation of intermediates such as nitrosamines, but can also inhibit some DNA repair processes. We have studied the inactivation of AGT by NO in detail in vitro and in vivo using wild-type human AGT (hAGT) and mutants at key residues. Our results show that hAGT is readily but reversibly inactivated by the formation of S-nitrosylcysteine at Cys-145, which is the alkyl acceptor site. The facile reaction of this cysteine residue with NO is attributable to its interaction with other residues in hAGT including His-146 and Glu-172 that activate the sulfhydryl group of Cys-145 to allow its nucleophilic attack on DNA adducts. Although the S-nitrosylcysteine adduct in hAGT is readily reversible by reaction with other cellular thiols, the formation of S-nitrosocysteine at Cys-145 was found to lead to the rapid degradation of the hAGT protein in vivo. This degradation is brought about by the ubiquitin/proteasomal system. The formation of an S-nitrosylcysteine at Cys-145 in hAGT in response to NO led to a large increase in the ubiquitination of the protein. This NO-mediated increase did not occur with the C145S or C145A mutants. A conformational change in hAGT, which involves opening of an asparagine hinge, normally occurs after alkylation of the protein in its role in DNA repair and causes degradation of the alkylated hAGT. Our results indicate that a similar effect occurs after reaction of the protein with NO. Thus, exposure to NO causes an irreversible loss of DNA repair capacity for alkylation adducts. This may contribute toward the potential development of tumors in cells upon chronic exposure to NO because of inflammation or infection. This may be of particular importance because such exposure may also lead to the formation of N-nitroso compounds that can act as alkylating agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036910

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

1.  Relatively small increases in the steady-state levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide.

Authors:  Min Dong; Peter C Dedon
Journal:  Chem Res Toxicol       Date:  2006-01       Impact factor: 3.739

2.  Repair of O6-G-alkyl-O6-G interstrand cross-links by human O6-alkylguanine-DNA alkyltransferase.

Authors:  Qingming Fang; Anne M Noronha; Sebastian P Murphy; Christopher J Wilds; Julie L Tubbs; John A Tainer; Goutam Chowdhury; F Peter Guengerich; Anthony E Pegg
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

3.  Mass spectrometry based approach to study the kinetics of O6-alkylguanine DNA alkyltransferase-mediated repair of O6-pyridyloxobutyl-2'-deoxyguanosine adducts in DNA.

Authors:  Delshanee Kotandeniya; Dan Murphy; Uthpala Seneviratne; Rebecca Guza; Anthony Pegg; Sreenivas Kanugula; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2011-09-29       Impact factor: 3.739

4.  Repair of O4-alkylthymine by O6-alkylguanine-DNA alkyltransferases.

Authors:  Qingming Fang; Sreenivas Kanugula; Julie L Tubbs; John A Tainer; Anthony E Pegg
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

Review 5.  A new perspective on oxidation of DNA repair proteins and cancer.

Authors:  Khadijeh S Alnajjar; Joann B Sweasy
Journal:  DNA Repair (Amst)       Date:  2019-02-18

Review 6.  When saliva meets acid: chemical warfare at the oesophagogastric junction.

Authors:  K E L McColl
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Differential inactivation of polymorphic variants of human O6-alkylguanine-DNA alkyltransferase.

Authors:  Qingming Fang; Natalia A Loktionova; Robert C Moschel; Sahar Javanmard; Gary T Pauly; Anthony E Pegg
Journal:  Biochem Pharmacol       Date:  2007-10-02       Impact factor: 5.858

8.  The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity.

Authors:  Maya Remington; Jana Chtchetinin; Karen Ancheta; Phioanh Leia Nghiemphu; Timothy Cloughesy; Albert Lai
Journal:  Neuro Oncol       Date:  2008-09-23       Impact factor: 12.300

9.  Tumor-associated mutations in O⁶ -methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality.

Authors:  Kristy L Lamb; Yanfeng Liu; Kimiko Ishiguro; Youngho Kwon; Nicolas Paquet; Alan C Sartorelli; Patrick Sung; Sara Rockwell; Joann B Sweasy
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

10.  Hepatocarcinogenesis driven by GSNOR deficiency is prevented by iNOS inhibition.

Authors:  Chi-Hui Tang; Wei Wei; Martha A Hanes; Limin Liu
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.